Search Results for 'Biosimilars'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Cipla, Kemwell Enter Biosimilars Joint Venture
Partnership to focus on developing, manufacturing and commercializing biosimilars.08.30.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up
Partnership to support the development and manufacture of biosimilars for global customers.07.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity
Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.Tim Wright, Editor, Contract Pharma 03.25.21
-
Biologics, Proteins, Vaccines | Biosimilars | Drug Development
Biopharma Contract Manufacturing: Robust Growth Ahead
The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.William Downey, HighTech Business Decisions 11.17.20
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech and DKSH Extend Biosimilar Partnership in Asia
Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.Contract Pharma Staff 09.24.20
-
Biologics, Proteins, Vaccines | Biosimilars | R&D
The Global Biotech Boom
How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.Davide Garrisi, PPD Biotech 09.09.20
-
Biosimilars
Biosimilar Manufacturing Strategies
Five steps to competing in a post-patent expiry era.George I’ons, Owen Mumford Pharmaceutical Services 09.09.20
-
Biosimilars
The U.S. Biosimilars Market: Shaking the “Laggard” Label
Biosimilar uptake set to reshape the U.S. marketKatya Svoboda and Bob Swann, ICON 05.05.20
-
Breaking News | Financial Reports
Financial Report: Roche
Pharmaceutical sales up 3% in the quarter, driven by Tecentriq, Hemlibra, Ocrevus and Perjeta.Contract Pharma Staff 04.22.20
-
Aseptic Processing | Facilities | Fill/Finish
GRAM Continues Aggressive Expansion in Parenterals
Backed by Arlington Capital Partners, Grand River Aseptic Manufacturing invests in major expansion of capacity and capabilities with new fill finish facilityTim Wright, Editor, Contract Pharma 04.01.20
-
Breaking News | Industry News
FDA Issues Emergency Approval for Anti-Malaria Drugs
HHS accepts donations of hydroxychloroquine sulfate, chloroquine phosphate as possible treatments for COVID-19 patients03.30.20
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, DKSH Partner to Bring Biosimilar to Asia
Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech03.26.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development
Newsmakers: Thermo Fisher Scientific
Leon Wyszkowski discusses the company’s recent investments, the challenges biopharma companies face, and future needs in the outsourcing spaceOnline Exclusives03.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Univercells Secures up to €50M Investment
Will speed delivery of manufacturing technologies02.20.20
-
Breaking News | Financial Reports
Financial Report: Novartis
Pharmaceuticals sales up 12% in the quarter driven by Entresto and Cosentyx01.30.20
-
Breaking News | Financial Reports
-
Biosimilars
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, JAMP Pharma Ink Biosim Deal
Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.01.15.20
-
Drug Development | R&D
Top Pharma M&A Deals of 2019
Drug manufacturers spent a record $342 billion on Mergers & AcquisitionsOnline Exclusives Kristin Brooks, Contract Pharma 12.23.19
-
APIs
India to Track API Packs
India is mulling a shakeup in the regulations governing the distribution of pharmaceutical products.S. Harachand, Contributing Editor 11.20.19
-
When Life Gives You Lemons…Raise Your Drug Prices
The hidden effect of economic models on global drug supply and shortages.Ben Locwin 11.20.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
Biologics, Proteins, Vaccines
Cell and Gene Therapy Landscape
Heather Myler of PPD provides current insight into the growing field of Cell and Gene Therapies11.12.19
-
Breaking News | Industry News
Biogen, Samsung Bioepis Enter New Biosimilars Transaction
Secures exclusive rights to commercialize ophthalmology biosimilars referencing Lucentis and Eylea11.07.19
-
Shortfalls in Advanced Therapy Production & Growth in China Bio Capacity
CPhI Annual Report says a shortage of qualified personnel may be a drag factor in cell and gene therapies.Online Exclusives11.05.19
-
Biologics, Proteins, Vaccines | Biosimilars
Europe to Surpass U.S. Biologic Manufacturing Capacity by 2023
CPhI Annual Report says demand for biological manufacturing is growing faster than capacity growth.Online Exclusives11.04.19
-
Contract Pharma’s 20th Anniversary Retrospective
A look back a the pharma/biopharma industry and the future of outsourcing.Kristin Brooks, Managing Editor, Contract Pharma 10.15.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Horizon, Glenmark Sign Biomfg. License Agreement
For GS knockout CHO cell line for manufacture of biotherapeutics09.30.19
-
Biosimilars
The Bioprocessing Trek
Biosimilars are the next speed-bump for CMOsEmil W. Ciurczak, DoraMaxx Consulting 09.16.19
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance
Lonza’s biologics facility in Singapore to cover EU and U.S. market needs09.03.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Alvotech, Prestige Biopharma Enter New Manufacturing Partnership
Alvotech Contract Services to make one of Prestige’s biosimilar candidates08.28.19
-
Breaking News | Industry News
Mylan and Upjohn Join Forces
Creates new global pharma company; revenues expected in the $20bn range08.02.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, Cipla Gulf Ink Biosimilar Deal
Will partner for the commercialization of key biosimilar in select emerging markets07.29.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Pressure BioSciences Inks Contract Services Deal
Agreement utilizes its BaroFold protein refolding and disaggregation biopharma services07.25.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Facilities | Industry News
Celltrion, Nan Fung Group Set Up Bio CDMO in China
Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility07.19.19
-
-
-
-
-
Pharmaceutical Packaging Market Report
Key factors influencing the $70B market, overcoming rising costs, and opportunities on the horizon.Kristin Brooks, Managing Editor, Contract Pharma 06.13.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biotech Booms in the Yangtze River Valley
A look at forces shaping the course of biotech growth in ChinaDaniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19
-
Biologics, Proteins, Vaccines
Ebullient Bio CMOs
Firms see rich dividends from biosimilarsS. Harachand, Contributing Editor 05.07.19
-
Biologics, Proteins, Vaccines | Biosimilars
Are Biotech Companies Strong Investments?
Biotech capital raised via IPO has increased dramatically over the past couple of years.Jason Monteleone , CEO, Clinipace 05.07.19
-
Logistics | Supply Chain
The Pharma Supply Chain
Overcoming the challenges of today’s global pharma supply chain.Rich Quelch, Global Head of Marketing, Origin 05.07.19
-
High-Quality Insulin for Everyone
A look at the latest insulin inspection technology trends.Andreas Gross, Global Product Manager Inspection Technology Bosch Packaging Technology K.K. 05.07.19
-
Biologics, Proteins, Vaccines
The Biopharma Future
A look at current trends driving volume reductions in biopharmaceutical manufacturing and keys for successful outsourcing partnerships.Karl Pinto and Dave Cunningham, Goodwin Biotechnology 05.07.19
-
Financial Reports
Financial Report: Roche
Pharmaceutical sales up 12% in the quarter driven by Ocrevus, Perjeta and Tecentriq, and new haemophilia drug Hemlibra04.17.19
-
The Unfolding Pharma Product Mix
Should you be diversifying your product portfolio to include production of small molecules and biologics?Ben Locwin, Contributing Writer 04.05.19
-
Clinical Trial Materials | Clinical Trials
Clinical Trial Supply & Logistics
Market to witness major growth in coming yearsTim Wright, Editor 04.05.19
-
Clinical Trial Materials
CEO Spotlight: Salim Haffar
The chief executive talks industry trends, challenges and what’s in store for PCI Pharma Services as it continues its rapid growth and global expansion strategyTim Wright, Editor, Contract Pharma 04.05.19
